Last reviewed · How we verify
Naxcel (CEFTIOFUR)
Naxcel (ceftiofur) is a small molecule antibiotic originally developed by Pfizer and currently owned by Zoetis. It is used to treat various bacterial infections in animals, including respiratory and skin infections. Naxcel is a cephalosporin antibiotic that works by inhibiting bacterial cell wall synthesis, ultimately leading to bacterial cell death. The commercial status of Naxcel is patented, and it is not yet off-patent. Key safety considerations include potential allergic reactions and interactions with other medications.
At a glance
| Generic name | CEFTIOFUR |
|---|---|
| Modality | Small molecule |
| Therapeutic area | Metabolic |
| Phase | FDA-approved |